Duncan Community Residence has marked a momentous milestone—its golden anniversary. For 50 years, this facility has provided care to individuals living with chronic mental health disorders, underscoring the profound impact of local support and resources.

Texas is on track to reach a record number of whooping cough cases, with Bexar County already reporting over 200 infections among children. Officials and public health agencies emphasize preventative measures, particularly vaccination, to stem the growing tide of this respiratory disease.

A new gemcitabine intravesical system appears to lower the likelihood of radical cystectomy in high-risk, BCG-unresponsive non–muscle invasive bladder cancer. Published on Onclive, the article highlights how this therapy could significantly impact patient care moving forward.

Metformin, a commonly discussed medication in diabetes care, does not improve insulin resistance in Type 1 patients, according to a recent report. This finding may influence future considerations about its role for those managing Type 1 diabetes.

Illinois now has greater freedom to adopt its own vaccine rules following a bill signed by Governor J.B. Pritzker. The new law broadens the authority of the Illinois Department of Public Health to consider a wider range of scientific views, even those at odds with the CDC’s guidelines.

Brevard Health Alliance is improving hypertension control by using Rimidi’s remote patient monitoring platform and connected devices. This collaborative approach is yielding improved patient outcomes and driving plans to expand the program for enhanced community health.

The ultra-high-end CT scanners market is expected to reach USD 10.69 billion by 2034. Rising chronic disease prevalence and extraordinary advances in photon-counting technology are driving this growth, underscoring the global call for early and accurate diagnostic tools.

In a Phase 2a trial, INF904 demonstrated strong results for HS and CSU, with no safety signals reported. Early findings from this study suggest a potentially encouraging therapy option for these challenging conditions.

On December 1, 2025, Montreal’s Samuel De Champlain Bridge will glow a striking red from sunset onward. The colors commemorate World AIDS Day and Indigenous AIDS Awareness Week, shining a spotlight on international and local public health efforts.

A groundbreaking community laboratory in Wilmington, Delaware, is now growing patient-derived “mini tumors” to guide future cancer treatments. ChristianaCare’s new organoid core—described as the first-of-its-kind—could help pave the way for more precise therapies.

In an historic decision, the U.S. Food and Drug Administration has approved Itvisma, an adeno-associated virus vector-based gene therapy for spinal muscular atrophy. By extending eligibility to adults and children two years of age and older, this new treatment offers fresh hope for families coping with the disease.

Grueling treatments and social stigma define the challenges faced by TB patients in San Antonio. In October, survivors shared their stories with researchers, shedding light on the complexities of this disease and the resilience required to overcome it.

An unexpected vertigo attack in 2015 turned one writer’s life upside down, underscoring the steep challenges of treating chronic health issues. Through physical therapy, she regained some stability. Now, she calls upon society to recognize the importance of accessible, affordable health care coverage.

Emerging research suggests that starting hormone replacement therapy at the right moment could help maintain estrogen levels and reduce the risk of dementia in women. Doctors are investigating how timing may be key to safeguarding cognitive function.

GC Genome and Asan Medical Center have published their collaborative findings on a blood-based colorectal cancer screening method. The study, now featured in The American Journal of Gastroenterology, highlights the promise of liquid biopsy techniques in improving early cancer detection.

Doctors and researchers have long recognized that our immune system has the potential to fight cancer. Recent breakthroughs have finally allowed that principle to evolve into powerful, immune-based therapies that bring renewed hope.

Thanksgiving is a time for family, friends, and feasting—yet foodborne illnesses can quickly dampen the holiday spirit. This article underscores the vital role of proper precautions to ensure a joyful and healthy holiday celebration.

A live Charlotte Talks recording event is set to revisit the 1944 polio epidemic in Catawba County, examining how a close-knit community rallied in record time. This swift collaboration became known across North Carolina as the “Miracle of Hickory,” a testament to the power of unity against a public health threat.

Scientific research, once considered a bedrock of progress, is marred by retractions and fraudulent data. From AI-generated “findings” to dubious funding sources, a wave of deception threatens the credibility of modern science and undermines public trust.

In a surprising move, the U.S. government has halted $500 million in funding for groundbreaking mRNA vaccines. This decision comes despite mRNA technology’s strong record of saving millions of lives from respiratory threats like COVID-19 and the flu.

A new generation of portable oxygen concentrators aims to give people on oxygen therapy greater freedom. Inogen’s devices let users keep an active lifestyle while receiving necessary medical support. Learn how to access a free information kit to explore these mobile solutions.